These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21314995)

  • 1. Economic burden of illness of acute coronary syndromes: medical and productivity costs.
    Zhao Z; Winget M
    BMC Health Serv Res; 2011 Feb; 11():35. PubMed ID: 21314995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Social and Economic Costs and Health-Related Quality of Life in Patients With Acute Coronary Syndrome.
    Sheikhgholami S; Ebadifardazar F; Rezapoor A; Tajdini M; Salarifar M
    Value Health Reg Issues; 2021 May; 24():123-129. PubMed ID: 33571726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The economic burden of acute coronary syndromes for employees and their dependents: medical and productivity costs.
    Page RL; Ghushchyan V; Gifford B; Read RA; Raut M; Crivera C; Naim AB; Damaraju CV; Nair KV
    J Occup Environ Med; 2013 Jul; 55(7):761-7. PubMed ID: 23787565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indirect and direct costs of acute coronary syndromes with comorbid atrial fibrillation, heart failure, or both.
    Ghushchyan V; Nair KV; Page RL
    Vasc Health Risk Manag; 2015; 11():25-34. PubMed ID: 25565859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost of care for new versus recurrent acute coronary syndrome patients.
    Shetty S; Halpern R; McCollam PL
    J Med Econ; 2008; 11(1):81-99. PubMed ID: 19450112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic outcomes with prasugrel versus clopidogrel in acute coronary syndrome patients: observations from prasugrel users and matched clopidogrel users.
    Olson WH; Ma YW; Crivera C; Schein J; Lefebvre P; Laliberté F; Dea K; Germain G; Lynch SM
    J Med Econ; 2015; 18(12):1074-84. PubMed ID: 26407193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costs of payment in Thai acute coronary syndrome patients.
    Moleerergpoom W; Kanjanavanit R; Jintapakorn W; Sritara P
    J Med Assoc Thai; 2007 Oct; 90 Suppl 1():21-31. PubMed ID: 18431883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resource Utilization and Costs Associated With Percutaneous Coronary Intervention When Treating Patients With Acute Coronary Syndrome in the Mexican National Institute of Cardiology "Ignacio Chávez".
    Jones K; Ramirez J; Papadimitropoulos M; Lomelí OS; Vanegas HR; Cortina de la Rosa E; Izaguirre Ávila R
    Value Health Reg Issues; 2019 Dec; 20():136-141. PubMed ID: 31419609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and economic impact of coronary artery bypass graft and percutaneous coronary intervention in young individuals with acute coronary syndromes and multivessel disease: A real-world comparison in a middle-income country.
    Alexim GA; Rocha LF; Dobri GP; Rosa Júnior ADS; Reis RTB; Nogueira ACC; Soares AASM; Sposito AC; de Paula AP; de Carvalho LSF
    Front Cardiovasc Med; 2022; 9():1000260. PubMed ID: 36440021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total first-year costs of acute coronary syndrome in a managed care setting.
    Etemad LR; McCollam PL
    J Manag Care Pharm; 2005 May; 11(4):300-6. PubMed ID: 15871640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of acute coronary syndrome on clinical, economic, and cardiac-specific health status after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: 1-year results from the stent or surgery (SoS) trial.
    Zhang Z; Spertus JA; Mahoney EM; Booth J; Nugara F; Stables RH; Weintraub WS
    Am Heart J; 2005 Jul; 150(1):175-81. PubMed ID: 16084166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary artery bypass graft surgery in acute coronary syndrome: incidence, cost impact, and acute clopidogrel interruption.
    Johnston SS; Bell K; Gdovin J; Jing Y; Graham J
    Hosp Pract (1995); 2012 Feb; 40(1):15-23. PubMed ID: 22406879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment, outcomes, costs, and quality of life of women and men with acute coronary syndromes who have undergone percutaneous coronary intervention: results from the antiplatelet therapy observational registry.
    Bakhai A; Ferrières J; James S; Iñiguez A; Mohácsi A; Pavlides G; Belger M; Norrbacka K; Sartral M
    Postgrad Med; 2013 Mar; 125(2):100-7. PubMed ID: 23816776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct healthcare costs and resource consumption after acute coronary syndrome: a real-life analysis of an Italian subpopulation.
    Roggeri DP; Roggeri A; Rossi E; Cinconze E; De Rosa M; Maggioni AP;
    Eur J Prev Cardiol; 2014 Sep; 21(9):1090-6. PubMed ID: 23515447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
    Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
    J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Societal burden of cluster headache in the United States: a descriptive economic analysis.
    Ford JH; Nero D; Kim G; Chu BC; Fowler R; Ahl J; Martinez JM
    J Med Econ; 2018 Jan; 21(1):107-111. PubMed ID: 29125368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of multiple drug-eluting stent percutaneous coronary intervention and surgical revascularization in patients with multivessel coronary artery disease: one-year clinical results and total treatment costs.
    Varani E; Balducelli M; Vecchi G; Aquilina M; Maresta A
    J Invasive Cardiol; 2007 Nov; 19(11):469-75. PubMed ID: 17986722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United States.
    Bonafede M; Sapra S; Shah N; Tepper S; Cappell K; Desai P
    Headache; 2018 May; 58(5):700-714. PubMed ID: 29446063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic consequences of ACS-related rehospitalizations in the US.
    Berenson K; Ogbonnaya A; Casciano R; Makenbaeva D; Mozaffari E; Lamerato L; Corbelli J
    Curr Med Res Opin; 2010 Feb; 26(2):329-36. PubMed ID: 19968457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of multivessel percutaneous coronary intervention and coronary artery bypass grafting in patients with severe coronary artery disease presenting with non-ST-segment elevation acute coronary syndromes.
    Desperak P; Hawranek M; Hrapkowicz T; Zembala MO; Gąsior M
    Kardiol Pol; 2018; 76(10):1474-1481. PubMed ID: 30251246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.